Ascendis Pharma A/S Financials

Market Capitalization $7.62 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-14.99
Forward PE	-32.28
Price to Sales TTM	$24.01
Price to Book MRQ	$-72.31
Enterprise to Revenue	24.15
Enterprise to EBITDA	-22.09

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-154.12%
Operating Margin	-370.18%
Return on Assets TTM	-27.92%
Return on Equity TTM	330.44%

Income Statement

Revenue TTM	$332,944,022
Revenue per Share TTM	$5.60
Quarterly Revenue Growth	-24.00%
Gross Profit TTM	$284,853,801
EBITDA	$-363,934,638
Net Income to Common TTM	$-513,120,461
Diluted EPS TTM	$-7.76
Quarterly Earnings Growth YoY	20.40%

Balance Sheet

Total Cash MRQ	$271,170,321
Total Cash per Share MRQ	$4.51
Total Debt MRQ	$
Total Debt to Equity MRQ	-7.24
Current Ratio MRQ	0.74
Book Value per Share MRQ	$-2.57

Cash Flow

Operating Cash Flow TTM	$-345,995,417
Levered Free Cash Flow TTM	$-109,149,572

ASND Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	59,807,800
Float Shares	56,927,086
Avg 10 Volume	533,790
Avg 30 Volume	None
Shares Short	3,407,568
Short Ratio	8.50
Short % of Shares	8.03%
% Held by Insiders	0.73%
% Held by Institutions	107.12%

Stock Price Summary

Beta	0.65
Fifty Two Week Low	$111.09
Fifty Two Week High	$161.00
Fifty Two Week Change	-4.83%
Day 50 MA	$132.35
Day 200 MA	$133.74

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date